MANE peer analysis
Veradermics (MANE) against its competitors: price, today's move, 1-year return and market value side by side.
MANE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABEO Abeona Therapeutics | $2.46 | -3.35% | -41.55% | $140.39M |
| ADIL Adial Pharmaceuticals | $5.05 | 36.12% | -46.48% | $13.26M |
| DRMA Dermata Therapeutics | $0.74 | -3.88% | -75.65% | $2.98M |
| HELP Helus Pharma | $9.08 | -3.09% | – | $562.82M |
| LSTA Lisata Therapeutics | $1.12 | 8.74% | -45.63% | $10.09M |
| OVID Ovid Therapeutics | $2.79 | -1.93% | 111.74% | $545.86M |
| PLYX Polaryx Therapeutics | $1.94 | 7.78% | – | $96.70M |
| TVTX Travere Therapeutics | $51.98 | 0.68% | 60.73% | $4.99B |
| XTLB XTL Biopharmaceuticals | $1.53 | -1.28% | -62.13% | $1.45M |
| MANE Veradermics | $148.27 | 3.00% | – | $6.19B |
- MANE's peers: ABEO (Abeona Therapeutics), ADIL (Adial Pharmaceuticals), DRMA (Dermata Therapeutics), HELP (Helus Pharma), LSTA (Lisata Therapeutics), OVID (Ovid Therapeutics), PLYX (Polaryx Therapeutics), TVTX (Travere Therapeutics).
Updated 2026-11-11 00:49 UTC